Lilian Rose Pratt-Riccio

Dr. Lilian Rose Pratt-Riccio

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2013 in Malaria Journal
Verified
Journal Article
Open access
PDF file
EREvelyn Kp Riccio
Evelyn Kp Riccio
PTPaulo Renato Totino
Paulo Renato Totino
LPLilian Rose Pratt-Riccio
Lilian Rose Pratt-Riccio
Vítor Ennes-VidalVítor Ennes-Vidal
Vítor Ennes-Vidal
ISIrene Soares
Irene Soares
MCMaria de Fátima Ferreira da Cruz
Maria de Fátima Ferreira da Cruz
Plasmodium vivax merozoite surface protein-1 (MSP-1) is an antigen considered to be one of the leading malaria vaccine candidates. PvMSP-1 is highly immunogenic and evidences suggest that it is target for protective immunity against asexual blood stages of malaria parasites. Thus, this study aims to evaluate the acquired cellular and antibody immune responses against PvMSP-1 in individuals naturally exposed to malaria infections in a malaria-endemic area in the north-eastern Amazon region of Brazil.

1 December 2005 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
LPLilian Rose Pratt-Riccio
Lilian Rose Pratt-Riccio
JLJosué C. Lima-Junior
Josué C. Lima-Junior
LCLeonardo J. M. Carvalho
Leonardo J. M. Carvalho
MTMichael Theisen
Michael Theisen
EEErika C. Espíndola-Mendes
Erika C. Espíndola-Mendes
DBDalma M. Banic
Dalma M. Banic
The goal of this study was to evaluate the antibody response induced by Plasmodium falciparum glutamate-rich protein (GLURP) in naturally exposed individuals from the Brazilian Amazon region (Rondonia State). The results showed that most individuals had IgG against two well-defined regions within P. falciparum GLURP, the relatively conserved N-terminal nonrepeat region (R0) and the immunodominant repeat region (R2), 67% and 79%, respectively. The peptides S4 from R2 (53%) and P11 from R0 (49%) were identified as immunodominant B cell epitopes and induced higher levels of antibodies. The number of GLURP peptides recognized and the levels of IgG against S4 and P11 peptides showed a positive correlation with age and time of exposure in the malaria-endemic area studied. The antibody responses against GLURP epitopes appear to be modulated by HLA class II antigens. Interestingly, the GLURP immunodominant B cell epitopes in individuals from a Brazilian malaria-endemic area are distinguishable from those of the African malaria-endemic area. Considering the importance of GLURP as a malaria vaccine candidate and the increasing focus on the use of subunit vaccines in the control of infectious diseases, the concern of the influence of class II allele frequencies in ethnically diverse populations may be important before vaccine trials are conducted among people naturally exposed to malaria parasites.

4 January 2022 in Malaria Journal
Verified
Journal Article
Open access
PDF file
BBBarbara Oliveira Baptista
Barbara Oliveira Baptista
ASAna Beatriz Lopes de Souza
Ana Beatriz Lopes de Souza
EREvelyn Kety Pratt Riccio
Evelyn Kety Pratt Riccio
CBCesare Bianco-Junior
Cesare Bianco-Junior
PTPaulo Renato Rivas Totino
Paulo Renato Rivas Totino
LPLilian Rose Pratt-Riccio
Lilian Rose Pratt-Riccio
Background: The GMZ2.6c malaria vaccine candidate is a multi-stagePlasmodium falciparumchimeric protein which contains a fragment of the sexual-stage Pfs48/45-6C protein genetically fused to GMZ2, a fusion protein of GLURP and MSP-3, that has been shown to be well tolerated, safe and immunogenic in clinical trials performed in a malaria-endemic area of Africa. However, there is no data available on the antigenicity or immunogenicity of GMZ2.6c in humans. Considering that circulating parasites can be genetically distinct in different malaria-endemic areas and that host genetic factors can influence the immune response to vaccine antigens, it is important to verify the antigenicity, immunogenicity and the possibility of associated protection in individuals living in malaria-endemic areas with different epidemiological scenarios. Herein, the profile of antibody response against GMZ2.6c and its components (MSP-3, GLURP and Pfs48/45) in residents of the Brazilian Amazon naturally exposed to malaria, in areas with different levels of transmission, was evaluated.Methods: This study was performed using serum samples from 352 individuals from Cruzeiro do Sul and Mâncio Lima, in the state of Acre, and Guajará, in the state of Amazonas. Specific IgG, IgM, IgA and IgE antibodies and IgG subclasses were detected by Enzyme-Linked Immunosorbent Assay.Results: The results showed that GMZ2.6c protein was widely recognized by naturally acquired antibodies from individuals of the Brazilian endemic areas with different levels of transmission. The higher prevalence of individuals with antibodies against GMZ2.6c when compared to its individual components may suggest an additive effect of GLURP, MSP-3, and Pfs48/45 when inserted in a same construct. Furthermore, naturally malaria-exposed individuals predominantly had IgG1 and IgG3 cytophilic anti-GMZ2.6c antibodies, an important fact considering that the acquisition of anti-malaria protective immunity results from a delicate balance between cytophilic/non-cytophilic antibodies. Interestingly, anti-GMZ2.6c antibodies seem to increase with exposure to malaria infection and may contribute to parasite immunity.Conclusions: The data showed that GMZ2.6c protein is widely recognized by naturally acquired antibodies from individuals living in malaria-endemic areas in Brazil and that these may contribute to parasite immunity. These data highlight the importance of GMZ2.6c as a candidate for an anti-malarial vaccine.

30 July 2008 in Malaria Journal
Verified
Journal Article
Open access
PDF file
LPLilian Rose Pratt-Riccio
Lilian Rose Pratt-Riccio
SSSelma Sallenave-Sales
Selma Sallenave-Sales
JOJoseli Oliveira-Ferreira
Joseli Oliveira-Ferreira
BSBruno T da Silva
Bruno T da Silva
MGMonick Lindenmeyer Guimarães
Monick Lindenmeyer Guimarães
DBDalma M Banic
Dalma M Banic
Background: The Plasmodium falciparum P126 protein is an asexual blood-stage malaria vaccine candidate antigen. Antibodies against P126 are able to inhibit parasite growth in vitro, and a major parasite-inhibitory epitope has been recently mapped to its 47 kDa N-terminal extremity (octamer repeat domain – OR domain). The OR domain basically consists of six octamer units, but variation in the sequence and number of repeat units may appear in different alleles. The aim of the present study was to investigate the polymorphism of P126 N-terminal region OR domain in P. falciparum isolates from two Brazilian malaria endemic areas and its impact on anti-OR naturally acquired antibodies. Methods: The study was carried out in two villages, Candeias do Jamari (Rondonia state) and Peixoto de Azevedo (Mato Grosso state), both located in the south-western part of the Amazon region. The repetitive region of the gene encoding the P126 antigen was PCR amplified and sequenced with the di-deoxy chain termination procedure. The antibody response was evaluated by ELISA with the Nt47 synthetic peptide corresponding to the P126 OR-II domain. Results: Only two types of OR fragments were identified in the studied areas, one of 175 bp (OR-I) and other of 199 bp (OR-II). A predominance of the OR-II fragment was observed in Candeias do Jamari whereas in Peixoto de Azevedo both fragments OR-I and OR-II were frequent as well as mixed infection (both fragments simultaneously) reported here for the first time. Comparing the DNA sequencing of OR-I and OR-II fragments, there was a high conservation among predicted amino acid sequences of the P126 N-terminal extremity. Data of immune response demonstrated that the OR domain is highly immunogenic in natural conditions of exposure and that the polymorphism of the OR domain does not apparently influence the specific immune response. Conclusion: These findings confirm a limited genetic polymorphism of the P126 OR domain in P. falciparum isolates and that this limited genetic polymorphism does not seem to influence the development of a specific humoral immune response to P126 and its immunogenicity in the studied population.

18 April 2015 in Malaria Journal
Verified
Journal Article
Open access
PDF file
EREvelyn Kp Riccio
Evelyn Kp Riccio
LPLilian Rose Pratt-Riccio
Lilian Rose Pratt-Riccio
CBCesare Bianco-Júnior
Cesare Bianco-Júnior
VSViolette Sanchez
Violette Sanchez
PTPaulo Renato Totino
Paulo Renato Totino
CDCláudio Tadeu DANIEL Daniel-Ribeiro
Cláudio Tadeu DANIEL Daniel-Ribeiro
The neotropical, non-human primates (NHP) of the genus Saimiri and Aotus are recommended by the World Health Organization as experimental models for the study of human malaria because these animals can be infected with the same Plasmodium that cause malaria in humans. However, one limitation is the lack of immunological tools to assess the immune response in these models. The present study focuses on the development and comparative use of molecular and immunological methods to evaluate the cellular immune response in Saimiri sciureus. Blood samples were obtained from nineteen uninfected Saimiri. Peripheral blood mononuclear cells (PBMC) from these animals and splenocytes from one splenectomized animal were cultured for 6, 12, 18, 24, 48, 72 and 96 hrs in the presence of phorbol-12-myristate-13-acetate and ionomycin. The cytokine levels in the supernatant were detected using human and NHP cytometric bead array Th1/Th2 cytokine kits, the Bio-Plex Pro Human Cytokine Th1/Th2 Assay, enzyme-linked immunosorbent assay, enzyme-linked immunospot assays and intracellular cytokine secretion assays. Cytokine gene expression was examined through TaqMan® Gene Expression Real-Time PCR using predesigned human gene-specific primers and probes or primers and probes designed based on published S. sciureus cytokine sequences. The use of five assays based on monoclonal antibodies specific for human cytokines facilitated the detection of IL-2, IL-4 and/or IFN-γ. TaqMan array plates facilitated the detection of 12 of the 28 cytokines assayed. However, only seven cytokines (IL-1A, IL-2, IL-10, IL-12B, IL-17, IFN-β, and TNF) presented relative expression levels of at least 70% of the gene expression observed in human PBMC. The use of primers and probes specific for S. sciureus cytokines facilitated the detection of transcripts that showed relative expression below the threshold of 70%. The most efficient evaluation of cytokine gene expression, in PBMC and splenocytes, was observed after 6–12 hrs of culture, except for LTA in PBMC, whose expression was best analysed after 24 hrs of culture. Real-time PCR facilitates the analysis of a large number of cytokines altered during malaria infection, and this technique is considered the best tool for the evaluation of the cellular immune response in S. sciureus.

1 June 2013 in Memórias do Instituto Oswaldo Cruz
Verified
Journal Article
Open access
PDF file
LPLilian Rose Pratt-Riccio
Lilian Rose Pratt-Riccio
DPDaiana de Souza Perce-Da-Silva
Daiana de Souza Perce-Da-Silva
JLJosué da Costa Lima-Junior
Josué da Costa Lima-Junior
MTMichael Theisen
Michael Theisen
FSFatima Santos
Fatima Santos
DBDalma Maria Banic
Dalma Maria Banic
In Brazil, malaria is hypo to mesoendemic. It is present throughout the year with clear seasonal fluctuations and is frequently associated with the migratory movements of non-immune individuals to areas where malaria is endemic (Oliveira-Ferreira et al. 2010). Malaria remains a major public health concern in Brazil, where approximately 263,000 cases were registered in 2011, 99.8% of which were in the Amazon Region (SVS/MS 2012).